[Skip to Content]
[Skip to Content Landing]
Comment & Response
March 5, 2014

Deaths and Cardiovascular Events in Men Receiving Testosterone

Author Affiliations
  • 1Department of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson
  • 2Department of Pharmacy Practice, University of Connecticut, Storrs
  • 3Division of Endocrinology, University of Mississippi Medical Center, Jackson

Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2014;311(9):963-964. doi:10.1001/jama.2014.386

To the Editor A retrospective cohort study by Dr Vigen and colleagues1 evaluated the association between testosterone therapy for men with total testosterone levels of less than 300 ng/dL and a composite outcome (all-cause mortality, myocardial infarction, and stroke). Flaws in the design and population of this study may have affected the validity of the conclusions drawn by Vigen et al.1

First Page Preview View Large
First page PDF preview
First page PDF preview